Randomized open-label trial comparing topical prescription Triamcinolone (cas 124-94-7) to over-the-counter hydrocortisone for the treatment of phimosis
-
Add time:09/10/2019 Source:sciencedirect.com
SummaryBackgroundPhimosis is a common condition affecting most infant boys and generally resolves over time without symptoms. Severe cases of phimosis can lead to balanoposthitis, urinary tract infections, and urinary retention. Medical treatment for symptomatic phimosis includes topical corticosteroids with manual foreskin retraction.
We also recommend Trading Suppliers and Manufacturers of Triamcinolone (cas 124-94-7). Pls Click Website Link as below: cas 124-94-7 suppliers
Prev:Microfibrillar polymeric ocular inserts for Triamcinolone (cas 124-94-7) acetonide delivery
Next:Clinical PaperClinical PathologyRole of intralesional bleomycin and intralesional Triamcinolone (cas 124-94-7) therapy in residual haemangioma following propranolol) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Simultaneous determination of Triamcinolone (cas 124-94-7) hexacetonide and Triamcinolone (cas 124-94-7) acetonide in rabbit plasma using a highly sensitive and selective UPLC–MS/MS method10/01/2019
- From Lab to ClinicUrine Gene Expression Profiles in Bladder Pain Syndrome Patients Treated with Triamcinolone (cas 124-94-7)09/27/2019
- The role of vehicle metamorphosis on Triamcinolone (cas 124-94-7) acetonide delivery to the skin from microemulsions09/26/2019
- Case reportMiliary microemboli of the retinal arterioles and choriocapillaris after subcutaneous injection of Triamcinolone (cas 124-94-7) acetonide09/25/2019
- Clinical PaperClinical PathologyRole of intralesional bleomycin and intralesional Triamcinolone (cas 124-94-7) therapy in residual haemangioma following propranolol09/24/2019
- Microfibrillar polymeric ocular inserts for Triamcinolone (cas 124-94-7) acetonide delivery09/09/2019
- Comparison between the efficacy of intralesional rituximab versus intralesional Triamcinolone (cas 124-94-7) in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial09/08/2019
-
Health and Chemical more >